Fagron NV (OTCMKTS:ARSUF) Sees Significant Decrease in Short Interest

Fagron NV (OTCMKTS:ARSUF) saw a significant decline in short interest in the month of January. As of January 30th, there was short interest totaling 133 shares, a decline of 46.4% from the January 15th total of 248 shares. Based on an average trading volume of 2,000 shares, the days-to-cover ratio is presently 0.1 days. Based on an average trading volume of 2,000 shares, the days-to-cover ratio is presently 0.1 days.

Fagron Price Performance

ARSUF stock opened at $26.00 on Friday. The firm’s 50-day simple moving average is $24.76 and its 200 day simple moving average is $24.37. Fagron has a fifty-two week low of $23.50 and a fifty-two week high of $26.81.

About Fagron

Fagron (OTCMKTS:ARSUF) is a global pharmaceutical compounding company that supplies raw materials, equipment and services to compounding pharmacies, hospitals and healthcare practitioners. Its portfolio encompasses a range of pharmaceutical ingredients, dosage forms and specialized compounding solutions designed to meet patient-specific needs. The company supports the preparation of customized medications in areas such as dermatology, pain management, hormone replacement therapy and veterinary medicine, providing both sterile and non-sterile compounding products.

Headquartered in Rotterdam, the Netherlands, Fagron operates in more than 55 countries across Europe, the Americas, Asia-Pacific and the Middle East & Africa.